Nissen comments on DDMAC's needs to restrict DTC

Share this article:
Steven Nissen, head of cardiovascular medicine at Cleveland Clinic, wrote in the journal Nature that DDMAC “needs the right to restrict direct-to-consumer advertising during the first two years a drug is marketed and to preview advertising to ensure it is not misleading.” Nissen's missive, which also advised reevaluating user fees and nixing the last-minute policy change on off-label reprints, was included in a series advising President Obama. 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions